Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target

References

• Alagoz M, Chiang SC, Sharma A, et al. (2013). ATM deficiency results in accumulation of DNA-topoisomerase I covalent intermediates in neural cells. PLoS One 8:e58239
   PubMedGoogle Scholar
• Alagoz M, Wells OS, El-Khamisy SF. (2014). TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy. Nucleic Acids Res 42:3089–3103
   PubMed Web of Science ®Google Scholar
• Antony S, Marchand C, Stephen AG, et al. (2007). Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Res 35:4474–4484
   PubMed Web of Science ®Google Scholar
• Banerjee B, Roy A, Sen N, et al. (2010). A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani (LdTdp1) capable of removing topo I-DNA covalent complexes. Mol Microbiol 78:119–137
   PubMed Web of Science ®Google Scholar
• Barthelmes HU, Habermeyer M, Christensen MO, et al. (2004). TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II. J Biol Chem 279:55618–55625
   PubMed Web of Science ®Google Scholar
• Caldecott KW. (2003). DNA single-strand break repair and spinocerebellar ataxia. Cell 112:7–10
   PubMed Web of Science ®Google Scholar
• Caldecott KW. (2012). Tyrosyl DNA phosphodiesterase 2, an enzyme fit for purpose. Nat Struct Mol Biol 19:1212–1213
   PubMed Web of Science ®Google Scholar
• Champoux JJ. (2001a). DNA topoisomerase I-mediated nicking of circular duplex DNA. Methods Mol Biol 95:81–87
   PubMedGoogle Scholar
• Champoux JJ. (2001b). DNA topoisomerases: Structure, function, and mechanism. Annu Rev Biochem 70:369–413
   PubMed Web of Science ®Google Scholar
• Chen GL, Yang L, Rowe TC, et al. (1984). Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259:13560–13566
   PubMed Web of Science ®Google Scholar
• Chiang SC, Carroll J, El-Khamisy SF. (2010). TDP1 serine 81 promotes interaction with DNA ligase IIIalpha and facilitates cell survival following DNA damage. Cell Cycle 9:588–595
   PubMed Web of Science ®Google Scholar
• Conda-Sheridan M, Reddy PV, Morrell A, et al. (2013). Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1). J Med Chem 56:182–200
   PubMed Web of Science ®Google Scholar
• Cortes Ledesma F, El Khamisy SF, Zuma MC, et al. (2009). A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 461:674–678
   PubMed Web of Science ®Google Scholar
• Curtin NJ. (2012). DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer 12:801–817
   PubMed Web of Science ®Google Scholar
• Cymerman IA, Meiss G, Bujnicki JM. (2005). DNase II is a member of the phospholipase D superfamily. Bioinformatics 21:3959–3962
   PubMed Web of Science ®Google Scholar
• Das BB, Antony S, Gupta S, et al. (2009). Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J 28:3667–3680
   PubMed Web of Science ®Google Scholar
• Das BB, Dexheimer TS, Maddali K, et al. (2010). Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria. Proc Natl Acad Sci USA 107:19790–19795
   PubMed Web of Science ®Google Scholar
• Das BB, Huang SY, Murai J, et al. (2014). PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage. Nucleic Acids Res 42:4435–4449
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. (2002a). The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure 10:237–248
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. (2002b). Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. J Mol Biol 324:917–932
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. (2003). Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. Chem Biol 10:139–147
   PubMed Web of Science ®Google Scholar
• Davies DR, Interthal H, Champoux JJ, et al. (2004). Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes. J Med Chem 47:829–837
   PubMed Web of Science ®Google Scholar
• Dephoure N, Zhou C, Villen J, et al. (2008). A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 105:10762–10767
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Antony S, Marchand C, et al. (2008). Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med Chem 8:381–389
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Gediya LK, Stephen AG, et al. (2009). 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. J Med Chem 52:7122–7131
   PubMed Web of Science ®Google Scholar
• El-Khamisy SF, Caldecott KW. (2007). DNA single-strand break repair and spinocerebellar ataxia with axonal neuropathy-1. Neuroscience 145:1260–1266
   PubMed Web of Science ®Google Scholar
• El-Khamisy SF, Hartsuiker E, Caldecott KW. (2007). TDP1 facilitates repair of ionizing radiation-induced DNA single-strand breaks. DNA Repair (Amst) 6:1485–1495
   PubMed Web of Science ®Google Scholar
• El-Khamisy SF, Katyal S, Patel P, et al. (2009). Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin. DNA Repair (Amst) 8:760–766
   PubMed Web of Science ®Google Scholar
• El-Khamisy SF, Saifi GM, Weinfeld M, et al. (2005). Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434:108–113
   PubMed Web of Science ®Google Scholar
• Fam HK, Chowdhury MK, Walton C, et al. (2013a). Expression profile and mitochondrial colocalization of Tdp1 in peripheral human tissues. J Mol Histol 44:481–494
   PubMed Web of Science ®Google Scholar
• Fam HK, Walton C, Mitra SA, et al. (2013b). TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells. Mol Cancer Res 11:1179–1192
   PubMed Web of Science ®Google Scholar
• Gajewski S, Comeaux EQ, Jafari N, et al. (2012). Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: A member of the phospholipase D superfamily. J Mol Biol 415:741–758
   PubMed Web of Science ®Google Scholar
• Goto T, Wang JC. (1985). Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II. Proc Natl Acad Sci USA 82:7178–7182
   PubMed Web of Science ®Google Scholar
• Gottlin EB, Rudolph AE, Zhao Y, et al. (1998). Catalytic mechanism of the phospholipase D superfamily proceeds via a covalent phosphohistidine intermediate. Proc Natl Acad Sci USA 95:9202–9207
   PubMed Web of Science ®Google Scholar
• Graham FL, Smiley J, Russell WC, et al. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74
   PubMed Web of Science ®Google Scholar
• Hawkins AJ, Subler MA, Akopiants K, et al. (2009). In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation. DNA Repair (Amst) 8:654–663
   PubMed Web of Science ®Google Scholar
• He X, Van Waardenburg RC, Babaoglu K, et al. (2007). Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison. J Mol Biol 372:1070–1081
   PubMed Web of Science ®Google Scholar
• Hirano R, Interthal H, Huang C, et al. (2007). Spinocerebellar ataxia with axonal neuropathy: Consequence of a Tdp1 recessive neomorphic mutation? EMBO J 26:4732–4743
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Hertzberg R, Hecht S, et al. (1985). Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873–14878
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Lihou MG, Liu LF. (1989a). Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49:5077–5082
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Liu LF, Wall ME, et al. (1989b). DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Res 49:4385–4389
   PubMed Web of Science ®Google Scholar
• Huang SN, Pommier Y, Marchand C. (2011). Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin Ther Pat 21:1285–1292
   PubMed Web of Science ®Google Scholar
• Huang SY, Murai J, Dalla Rosa I, et al. (2013). TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res 41:7793–7803
   PubMed Web of Science ®Google Scholar
• Hudson JJ, Chiang SC, Wells OS, et al. (2012). SUMO modification of the neuroprotective protein TDP1 facilitates chromosomal single-strand break repair. Nat Commun 3:733
   PubMedGoogle Scholar
• Inamdar KV, Pouliot JJ, Zhou T, et al. (2002). Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1. J Biol Chem 277:27162–27168
   PubMed Web of Science ®Google Scholar
• Interthal H, Chen HJ, Champoux JJ. (2005a). Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages. J Biol Chem 280:36518–36528
   PubMed Web of Science ®Google Scholar
• Interthal H, Chen HJ, Kehl-Fie TE, et al. (2005b). SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivity. EMBO J 24:2224–2233
   PubMed Web of Science ®Google Scholar
• Interthal H, Pouliot JJ, Champoux JJ. (2001). The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci USA 98:12009–12014
   PubMed Web of Science ®Google Scholar
• Jaxel C, Capranico G, Kerrigan D, et al. (1991). Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J Biol Chem 266:20418–20423
   PubMed Web of Science ®Google Scholar
• Jilani A, Ramotar D, Slack C, et al. (1999). Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3′-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J Biol Chem 274:24176–24186
   PubMed Web of Science ®Google Scholar
• Karimi-Busheri F, Daly G, Robins P, et al. (1999). Molecular characterization of a human DNA kinase. J Biol Chem 274:24187–24194
   PubMed Web of Science ®Google Scholar
• Katyal S, El-Khamisy SF, Russell HR, et al. (2007). TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. EMBO J 26:4720–4731
   PubMed Web of Science ®Google Scholar
• Koster DA, Crut A, Shuman S, et al. (2010). Cellular strategies for regulating DNA supercoiling: A single-molecule perspective. Cell 142:519–530
   Google Scholar
• Koster DA, Palle K, Bot ES, et al. (2007). Antitumour drugs impede DNA uncoiling by topoisomerase I. Nature 448:213–217
   PubMed Web of Science ®Google Scholar
• Lanza A, Tornaletti S, Rodolfo C, et al. (1996). Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage. J Biol Chem 271:6978–6986
   PubMed Web of Science ®Google Scholar
• Lebedeva NA, Rechkunova NI, El-Khamisy SF, et al. (2012). Tyrosyl-DNA phosphodiesterase 1 initiates repair of apurinic/apyrimidinic sites. Biochimie 94:1749–1753
   PubMed Web of Science ®Google Scholar
• Lebedeva NA, Rechkunova NI, Ishchenko AA, et al. (2013). The mechanism of human tyrosyl-DNA phosphodiesterase 1 in the cleavage of AP site and its synthetic analogs. DNA Repair (Amst) 12:1037–1042
   PubMed Web of Science ®Google Scholar
• Lebedeva NA, Rechkunova NI, Lavrik OI. (2011). Ap-site cleavage activity of tyrosyl-dna phosphodiesterase 1. FEBS Lett 585:683–686
   PubMed Web of Science ®Google Scholar
• Lebedeva NA, Rechkunova NI, Lavrik OI. (2014). Repair of apurinic/apyrimidinic sites in single-stranded DNA initiated by tyrosyl-DNA phosphodiesterase 1. Dokl Biochem Biophys 455:68–71
   PubMed Web of Science ®Google Scholar
• Leiros I, Secundo F, Zambonelli C, et al. (2000). The first crystal structure of a phospholipase D. Structure 8:655–667
   PubMed Web of Science ®Google Scholar
• Liao Z, Thibaut L, Jobson A, et al. (2006). Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors. Mol Pharmacol 70:366–372
   PubMed Web of Science ®Google Scholar
• Liu C, Pouliot JJ, Nash HA. (2002). Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1. Proc Natl Acad Sci USA 99:14970–14975
   PubMed Web of Science ®Google Scholar
• Liu C, Pouliot JJ, Nash HA. (2004). The role of TDP1 from budding yeast in the repair of DNA damage. DNA Repair (Amst) 3:593–601
   PubMed Web of Science ®Google Scholar
• Lynn RM, Bjornsti MA, Caron PR, et al. (1989). Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Proc Natl Acad Sci USA 86:3559–3563
   PubMed Web of Science ®Google Scholar
• Marchand C, Lea WA, Jadhav A, et al. (2009). Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay. Mol Cancer Ther 8:240–248
   PubMed Web of Science ®Google Scholar
• Mckinnon PJ. (2013). Maintaining genome stability in the nervous system. Nat Neurosci 16:1523–1529
   PubMed Web of Science ®Google Scholar
• Miao ZH, Agama K, Sordet O, et al. (2006). Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes. DNA Repair (Amst) 5:1489–1494
   PubMed Web of Science ®Google Scholar
• Moore PB, Steitz TA. (2003). The structural basis of large ribosomal subunit function. Annu Rev Biochem 72:813–850
   PubMed Web of Science ®Google Scholar
• Murai J, Huang SY, Das BB, et al. (2012). Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells. J Biol Chem 287:12848–12857
   PubMed Web of Science ®Google Scholar
• Murai J, Marchand C, Shahane SA, et al. (2014). Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform. DNA Repair (Amst) 21:177–182
   Google Scholar
• Nguyen TX, Morrell A, Conda-Sheridan M, et al. (2012). Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors. J Med Chem 55:4457–4478
   PubMed Web of Science ®Google Scholar
• Nick Mcelhinny SA, Kumar D, Clark AB, et al. (2010a). Genome instability due to ribonucleotide incorporation into DNA. Nat Chem Biol 6:774–781
   PubMed Web of Science ®Google Scholar
• Nick Mcelhinny SA, Watts BE, Kumar D, et al. (2010b). Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc Natl Acad Sci USA 107:4949–4954
   PubMed Web of Science ®Google Scholar
• Nitiss J, Wang JC. (1988). DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 85:7501–7505
   PubMed Web of Science ®Google Scholar
• Nitiss KC, Malik M, He X, et al. (2006). Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage. Proc Natl Acad Sci USA 103:8953–8958
   PubMed Web of Science ®Google Scholar
• Nivens MC, Felder T, Galloway AH, et al. (2004). Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase. Cancer Chemother Pharmacol 53:107–115
   PubMed Web of Science ®Google Scholar
• O'Connor PM, Kerrigan D, Bertrand R, et al. (1990). 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells. Cancer Commun 2:395–400
   PubMed Web of Science ®Google Scholar
• Perego P, Cossa G, Tinelli S, et al. (2012). Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition. Biochem Pharmacol 83:27–36
   PubMed Web of Science ®Google Scholar
• Pommier Y, Huang SY, Gao R, et al. (2014). Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair (Amst) 19:114–129
   PubMed Web of Science ®Google Scholar
• Pommier Y, Kohlhagen G, Pourquier P, et al. (2000). Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc Natl Acad Sci USA 97:2040–2045
   PubMed Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, et al. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421–433
   PubMed Web of Science ®Google Scholar
• Ponting CP, Kerr ID. (1996). A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: Identification of duplicated repeats and potential active site residues. Protein Sci 5:914–922
   PubMed Web of Science ®Google Scholar
• Postow L, Crisona NJ, Peter BJ, et al. (2001). Topological challenges to DNA replication: Conformations at the fork. Proc Natl Acad Sci USA 98:8219–8226
   PubMed Web of Science ®Google Scholar
• Pouliot JJ, Robertson CA, Nash HA. (2001). Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae. Genes Cells 6:677–687
   PubMed Web of Science ®Google Scholar
• Pouliot JJ, Yao KC, Robertson CA, et al. (1999). Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science 286:552–555
   PubMed Web of Science ®Google Scholar
• Pourquier P, Gioffre C, Kohlhagen G, et al. (2002). Gemcitabine (2′,2′-difluoro-2′-deoxycytidine), an antimetabolite that poisons topoisomerase I. Clin Cancer Res 8:2499–2504
   PubMed Web of Science ®Google Scholar
• Pourquier P, Pilon AA, Kohlhagen G, et al. (1997a). Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J Biol Chem 272:26441–26447
   PubMed Web of Science ®Google Scholar
• Pourquier P, Takebayashi Y, Urasaki Y, et al. (2000). Induction of topoisomerase I cleavage complexes by 1-beta-D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells. Proc Natl Acad Sci USA 97:1885–1890
   PubMed Web of Science ®Google Scholar
• Pourquier P, Ueng LM, Fertala J, et al. (1999). Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7,8-Dihydro-8-oxoguanine and 5-hydroxycytosine. J Biol Chem 274:8516–8523
   PubMed Web of Science ®Google Scholar
• Pourquier P, Ueng LM, Kohlhagen G, et al. (1997b). Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J Biol Chem 272:7792–7796
   PubMed Web of Science ®Google Scholar
• Pourquier P, Waltman JL, Urasaki Y, et al. (2001). Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: Trapping of topoisomerase I by the O6-methylguanine. Cancer Res 61:53–58
   PubMed Web of Science ®Google Scholar
• Raymond AC, Rideout MC, Staker B, et al. (2004). Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues. J Mol Biol 338:895–906
   PubMed Web of Science ®Google Scholar
• Raymond AC, Staker BL, Burgin AB Jr. (2005). Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1). J Biol Chem 280:22029–22035
   PubMed Web of Science ®Google Scholar
• Redinbo MR, Stewart L, Kuhn P, et al. (1998). Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279:1504–1513
   PubMed Web of Science ®Google Scholar
• Reijns MA, Rabe B, Rigby RE, et al. (2012). Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 149:1008–1022
   PubMed Web of Science ®Google Scholar
• Ross W, Rowe T, Glisson B, et al. (1984). Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res 44:5857–5860
   PubMed Web of Science ®Google Scholar
• Rulten SL, Caldecott KW. (2013). DNA strand break repair and neurodegeneration. DNA Repair (Amst) 12:558–567
   PubMed Web of Science ®Google Scholar
• Sapranauskas R, Sasnauskas G, Lagunavicius A, et al. (2000). Novel subtype of type IIs restriction enzymes. BfiI endonuclease exhibits similarities to the EDTA-resistant nuclease Nuc of Salmonella typhimurium. J Biol Chem 275:30878–30885
   PubMed Web of Science ®Google Scholar
• Schoeffler AJ, Berger JM. (2008). DNA topoisomerases: Harnessing and constraining energy to govern chromosome topology. Q Rev Biophys 41:41–101
   PubMed Web of Science ®Google Scholar
• Schroeder SC, Schwer B, Shuman S, et al. (2000). Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev 14:2435–2440
   PubMed Web of Science ®Google Scholar
• Segal-Raz H, Mass G, Baranes-Bachar K, et al. (2011). ATM-mediated phosphorylation of polynucleotide kinase/phosphatase is required for effective DNA double-strand break repair. EMBO Rep 12:713–719
   PubMed Web of Science ®Google Scholar
• Shaw G, Morse S, Ararat M, et al. (2002). Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869–871
   PubMed Web of Science ®Google Scholar
• Soeiro MN, Werbovetz K, Boykin DW, et al. (2013). Novel amidines and analogues as promising agents against intracellular parasites: A systematic review. Parasitology 140:929–951
   PubMed Web of Science ®Google Scholar
• Staker BL, Hjerrild K, Feese MD, et al. (2002). The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci USA 99:15387–15392
   PubMed Web of Science ®Google Scholar
• Stewart L, Redinbo MR, Qiu X, et al. (1998). A model for the mechanism of human topoisomerase I. Science 279:1534–1541
   PubMed Web of Science ®Google Scholar
• Stuckey JA, Dixon JE. (1999). Crystal structure of a phospholipase D family member. Nat Struct Biol 6:278–284
   PubMedGoogle Scholar
• Subramanian D, Rosenstein BS, Muller MT. (1998). Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: Possible relationship with DNA repair. Cancer Res 58:976–984
   PubMed Web of Science ®Google Scholar
• Swarup G, Cohen S, Garbers DL. (1982). Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun 107:1104–1109
   PubMed Web of Science ®Google Scholar
• Takagi M, Ueda JY, Hwang JH, et al. (2012). Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus. J Nat Prod 75:764–767
   PubMed Web of Science ®Google Scholar
• Takashima H, Boerkoel CF, John J, et al. (2002). Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 32:267–272
   PubMed Web of Science ®Google Scholar
• Takebayashi Y, Pourquier P, Yoshida A, et al. (1999). Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove. Proc Natl Acad Sci USA 96:7196–7201
   PubMed Web of Science ®Google Scholar
• Tumbale P, Appel CD, Kraehenbuehl R, et al. (2011). Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease. Nat Struct Mol Biol 18:1189–1195
   Google Scholar
• van der Merwe M, Bjornsti MA. (2008). Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin. J Biol Chem 283:3305–3315
   PubMed Web of Science ®Google Scholar
• van Waardenburg RC, De Jong LA, Van Delft F, et al. (2004a). Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons. Mol Cancer Ther 3:393–402
   PubMed Web of Science ®Google Scholar
• van Waardenburg RC, De Jong LA, Van Eijndhoven MAJ, et al. (2004b). Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin. J Biol Chem 279:54502–54509
   PubMed Web of Science ®Google Scholar
• Vance JR, Wilson TE. (2001). Uncoupling of 3′-phosphatase and 5′-kinase functions in budding yeast. Characterization of Saccharomyces cerevisiae DNA 3′-phosphatase (TPP1). J Biol Chem 276:15073–15081
   PubMed Web of Science ®Google Scholar
• Wang JC. (2002). Cellular roles of DNA topoisomerases: A molecular perspective. Nat Rev Mol Cell Biol 3:430–440
   PubMed Web of Science ®Google Scholar
• Weidlich IE, Dexheimer T, Marchand C, et al. (2010). Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores. Bioorg Med Chem 18:182–189
   PubMed Web of Science ®Google Scholar
• Whitehouse CJ, Taylor RM, Thistlethwaite A, et al. (2001). XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104:107–117
   PubMed Web of Science ®Google Scholar
• Williams JS, Clausen AR, Nick Mcelhinny SA, et al. (2012). Proofreading of ribonucleotides inserted into DNA by yeast DNA polymerase varepsilon. DNA Repair (Amst) 11:649–656
   PubMed Web of Science ®Google Scholar
• Williams JS, Smith DJ, Marjavaara L, et al. (2013). Topoisomerase 1-mediated removal of ribonucleotides from nascent leading-strand DNA. Mol Cell 49:1010–1015
   PubMed Web of Science ®Google Scholar
• Yang SW, Burgin AB Jr, Huizenga BN, et al. (1996). A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci USA 93:11534–11539
   PubMed Web of Science ®Google Scholar
• Zeng Z, Sharma A, Ju L, et al. (2012). TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1. Nucleic Acids Res 40:8371–8380
   PubMed Web of Science ®Google Scholar
• Zhou T, Akopiants K, Mohapatra S, et al. (2009). Tyrosyl-DNA phosphodiesterase and the repair of 3′-phosphoglycolate-terminated DNA double-strand breaks. DNA Repair (Amst) 8:901–911
   PubMed Web of Science ®Google Scholar
• Zhou T, Lee JW, Tatavarthi H, et al. (2005). Deficiency in 3′-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res 33:289–297
   PubMed Web of Science ®Google Scholar